Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial.
Saved in:
| Title: | Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial. |
|---|---|
| Authors: | Starling, Amaal J.1 (AUTHOR), Kudrow, David2 (AUTHOR), Kapur, Neha3 (AUTHOR), Awad, Susanne F.4 (AUTHOR) suaw@lundbeck.com, Grossman, S. Wald3 (AUTHOR), Patel, Foram3 (AUTHOR), Ailani, Jessica5 (AUTHOR), Blumenfeld, Andrew6,7 (AUTHOR), Lipton, Richard B.8 (AUTHOR) |
| Source: | Pain & Therapy. Jun2026, Vol. 15 Issue 3, p785-801. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938237 |
|---|---|
| DOI: | 10.1007/s40122-026-00831-0 |
